168 related articles for article (PubMed ID: 9783914)
1. Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice.
Llovera M; García-Martínez C; López-Soriano J; Carbó N; Agell N; López-Soriano FJ; Argiles JM
Mol Cell Endocrinol; 1998 Jul; 142(1-2):183-9. PubMed ID: 9783914
[TBL] [Abstract][Full Text] [Related]
2. Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1.
Llovera M; García-Martínez C; López-Soriano J; Agell N; López-Soriano FJ; Garcia I; Argilés JM
Cancer Lett; 1998 Aug; 130(1-2):19-27. PubMed ID: 9751252
[TBL] [Abstract][Full Text] [Related]
3. Lipid metabolism in tumour-bearing mice: studies with knockout mice for tumour necrosis factor receptor 1 protein.
López-Soriano J; Llovera M; Carbó N; García-Martínez C; López-Soriano FJ; Argiles JM
Mol Cell Endocrinol; 1997 Sep; 132(1-2):93-9. PubMed ID: 9324050
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha is involved in activating DNA fragmentation in skeletal muscle.
Carbó N; Busquets S; van Royen M; Alvarez B; López-Soriano FJ; Argilés JM
Br J Cancer; 2002 Mar; 86(6):1012-6. PubMed ID: 11953838
[TBL] [Abstract][Full Text] [Related]
5. Cancer cachexia results in an increase in TNF-alpha receptor gene expression in both skeletal muscle and adipose tissue.
Figueras M; Busquets S; Carbó N; Almendro V; Argilés JM; López-Soriano FJ
Int J Oncol; 2005 Sep; 27(3):855-60. PubMed ID: 16077938
[TBL] [Abstract][Full Text] [Related]
6. Loss of skeletal muscle in cancer: biochemical mechanisms.
Tisdale MJ
Front Biosci; 2001 Feb; 6():D164-74. PubMed ID: 11171557
[TBL] [Abstract][Full Text] [Related]
7. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
8. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis.
Llovera M; Garcia-Martinez C; Agell N; Lopez-Soriano FJ; Argiles JM
Int J Cancer; 1995 Mar; 61(1):138-41. PubMed ID: 7705927
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.
Puppa MJ; Gao S; Narsale AA; Carson JA
FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
11. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.
Cahlin C; Körner A; Axelsson H; Wang W; Lundholm K; Svanberg E
Cancer Res; 2000 Oct; 60(19):5488-93. PubMed ID: 11034092
[TBL] [Abstract][Full Text] [Related]
12. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
13. Cancer cachexia in a mouse model of oxidative stress.
Brown JL; Lawrence MM; Ahn B; Kneis P; Piekarz KM; Qaisar R; Ranjit R; Bian J; Pharaoh G; Brown C; Peelor FF; Kinter MT; Miller BF; Richardson A; Van Remmen H
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1688-1704. PubMed ID: 32918528
[TBL] [Abstract][Full Text] [Related]
14. Comparative molecular analysis of early and late cancer cachexia-induced muscle wasting in mouse models.
Sun R; Zhang S; Lu X; Hu W; Lou N; Zhao Y; Zhou J; Zhang X; Yang H
Oncol Rep; 2016 Dec; 36(6):3291-3302. PubMed ID: 27748895
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of muscle protein degradation induced by a cancer cachectic factor.
Lorite MJ; Thompson MG; Drake JL; Carling G; Tisdale MJ
Br J Cancer; 1998 Oct; 78(7):850-6. PubMed ID: 9764574
[TBL] [Abstract][Full Text] [Related]
16. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia.
Catalano MG; Fortunati N; Arena K; Costelli P; Aragno M; Danni O; Boccuzzi G
Int J Oncol; 2003 Aug; 23(2):429-36. PubMed ID: 12851692
[TBL] [Abstract][Full Text] [Related]
17. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats.
Llovera M; Carbó N; García-Martínez C; Costelli P; Tessitore L; Baccino FM; Agell N; Bagby GJ; López-Soriano FJ; Argilés JM
Biochem Biophys Res Commun; 1996 Apr; 221(3):653-5. PubMed ID: 8630016
[TBL] [Abstract][Full Text] [Related]
19. Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma.
Carbó N; Costelli P; Busquets S; López-Soriano J; López-Soriano FJ; Baccino FM; Argilés JM
Int J Mol Med; 2004 Oct; 14(4):719-23. PubMed ID: 15375607
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
